Stay updated on Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.

Latest updates to the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe UI was updated to Revision: v3.4.2 and the obsolete government-funding notice was removed; no study details were changed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about the lapse in government funding and the NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and a new revision indicator (v3.4.0). Minor wording updates to the QC date label and the No FEAR Act data notice, including removal of the old v3.3.4 reference.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study details or user-facing features.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with Oklahoma and Utah and updated to Revision: v3.3.3; removed the HHS Vulnerability Disclosure footer.SummaryDifference0.4%

- Check85 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2; no study content changes detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of SubQ DMB-3115 vs Stelara in Psoriasis Clinical Trial page.